How is mitomycin given (administered)?
Mitomycin may be administered into a vein (intravenous) and the dose depends on several factors, including the condition being treated, the size of the patient, the particular treatment regimen being used, and the overall health of the patient. If mitomycin leaks from the vein into which it is being administered, it may cause serious damage to the surrounding tissue. Although patients will be monitored for this, they should tell their healthcare provider immediately if they experience pain, redness, or swelling at the site in which the drug is being administered. How are patients monitored? Patients will usually have scheduled meetings with their healthcare provider while they are being treated with mitomycin. Typically, blood will be drawn to check levels of blood cells and to monitor functions of some organ systems, such as the kidneys or liver. Patients may also undergo physical examinations, scans or other measures to assess side effects and response to therapy. Patients will also
